Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults
- 19 August 2014
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 161 (4) , 242-248
Abstract
Several adverse outcomes attributed to atypical antipsychotic drugs, specifically quetiapine, risperidone, and olanzapine, are known to cause acute kidney injury (AKI). Such outcomes include hypotension, acute urinary retention, and the neuroleptic malignant syndrome or rhabdomyolysis. To investigate the risk for AKI and other adverse outcomes associated with use of atypical antipsychotic drugs versus nonuse. Population-based cohort study. Ontario, Canada, from 2003 to 2012. Adults aged 65 years or older who received a new outpatient prescription for an oral atypical antipsychotic drug (n=97,777) matched 1:1 with those who did not receive such a prescription. The primary outcome was hospitalization with AKI (assessed by using a hospital diagnosis code and, in a subpopulation, serum creatinine levels) within 90 days of prescription for atypical antipsychotic drugs. Atypical antipsychotic drug use versus nonuse was associated with a higher risk for hospitalization with AKI (relative risk [RR], 1.73 [95% CI, 1.55 to 1.92]). This association was consistent when AKI was assessed in a subpopulation for which information on serum creatinine levels was available (5.46% vs. 3.34%; RR, 1.70 [CI, 1.22 to 2.38]; absolute risk increase, 2.12% [CI, 0.80% to 3.43%]). Drug use was also associated with hypotension (RR, 1.91 [CI, 1.60 to 2.28]), acute urinary retention (RR, 1.98 [CI, 1.63 to 2.40]), and all-cause mortality (RR, 2.39 [CI, 2.28 to 2.50]). Only older adults were included in the study. Atypical antipsychotic drug use is associated with an increased risk for AKI and other adverse outcomes that may explain the observed association with AKI. The findings support current safety concerns about the use of these drugs in older adults. Academic Medical Organization of Southwestern Ontario.Keywords
This publication has 31 references indexed in Scilit:
- Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney InjuryJAMA, 2013
- Antipsychotic Use and Myocardial Infarction in Older Patients With Treated DementiaArchives of internal medicine (1960), 2012
- Orlistat and Acute Kidney Injury: An Analysis of 953 PatientsArchives of internal medicine (1960), 2011
- Neuroleptic Malignant Syndrome Presenting with Acute Renal FailureProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Olanzapine and acute urinary retention in two geriatric patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months durationInternational Journal of Geriatric Psychiatry, 2006
- Antipsychotic Drugs in Dementia2005
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJAMA, 2005
- Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population-based comparisonJACC, 1996
- Risperidone-induced neuroleptic malignant syndrome in young patientThe Lancet, 1994